
IVIG (Intravenous Immunoglobulin) solution
Form: Intravenous infusion
Strength: 5% or 10%
Reference Brands: Gammagard (Gamunex-C, Flebogamma),Privigen, Octagam, Gamunex-C(US)
Category: Immune Disorder
IVIG (Intravenous Immunoglobulin) solution, marketed as Gammagard or Privigen, is approved in the US by the FDA and in the EU via EMA for passive immunity against specific infections, such as varicella-zoster and other viral diseases. Regulatory approval requires a detailed dossier including clinical efficacy, safety, manufacturing quality, and pharmacovigilance plans. In the US, the FDA rigorously reviews clinical trial and production data, while the EMA ensures compliance with regional safety and quality standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper compliance is essential for timely approval and safe use of VIG products worldwide, supporting effective infection prevention.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Belimumab prefilled syringe
Strength: 200 mg/ten 1 mL for SQ; 10 mg/mL for IV
Form: Subcutaneous (SC) and intravenous (IV) Prefilled syringe
Reference Brands: Benlysta(US & EU)
View Details Get EnquiryAnakinra injection
Strength: 100 mg/mL
Form: Injection(SQ)
Reference Brands: Kinerso, Kineret(US)
View Details Get EnquiryUstekinumab Injection
Strength: SQ:: 45 mg, 90 mg; IV: 130 mg/vial
Form: SQ and IV injection
Reference Brands: Stelara(US)
View Details Get EnquiryEverolimus tablets
Strength: 0.75 mg, 1.25 mg, 2.5 mg, 5 mg, 7.5 mg, 10 mg
Form: Tablet
Reference Brands: Zortress, Afinitor(US & EU)
View Details Get Enquiry